Telephone follow-up for patients with amyotrophic lateral sclerosis

European Journal of Neurology

Volumn 14, Issue 1, 2007, Pages 79-84

  Mannino, M ^a   Cellura, E ^a   Grimaldi, G ^a   Volanti, P ^a   Piccoli, F ^a   La Bella, V ^a,b  

^a UNIVERSITY OF PALERMO   (Italy)

^b Department of Neurology and Psychiatry   (Italy)

Author keywords

Amyotrophic lateral sclerosis; Amyotrophic lateral sclerosis functional rating scale; Disease progression; Telephone interview

Indexed keywords

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; AMYOTROPHIC LATERAL SCLEROSIS FUNCTIONAL RATING SCALE; ARTICLE; BREATHING DISORDER; CAREGIVER; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL EVALUATION; CONSTIPATION; CONTROLLED STUDY; DISEASE COURSE; DYSPHAGIA; FEMALE; FOLLOW UP; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; LUNG; MALE; MUSCLE STRENGTH; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; TELEPHONE; UNSTRUCTURED INTERVIEW;

ACTIVITIES OF DAILY LIVING; AGED; AMYOTROPHIC LATERAL SCLEROSIS; CAREGIVERS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERVIEWS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 33846181344     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2006.01559.x     Document Type: Article

References (16)

1. Rao JN. Follow up by telephone. British Medical Journal 1994; 309: 1527-1528.
2. Brada M, James ND. Phone clinic provides excellent support. British Medical Journal 1995; 310: 738.
3. Allen HF, Yarnie S, Murray NA, Reiter EO. Personnel costs and perceived benefit of telephone care in the management of children with type 1 diabetes. Pediatric Diabetes 2002; 3: 95-100.
4. Group ACTS Phase I-II. The amyotrophic lateral sclerosis functional rating scale: assessment of activities of daily living in patients with amyotrophic lateral sclerosis. Archives of Neurology 1996; 53: 141-147.
5. Cedarbaum JM, Stambler N, Malta E, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. Journal of the Neurological Sciences 1999; 169: 13-21.
6. Group ACTS. A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. Neurology 1996; 46: 1244-1249.
7. BDNF Study Group, Phase III. A controlled trial of recombinant methionyl human BDNF in ALS. Neurology 1999; 52: 1427-1433.
8. Miller RG, Moore DH, Gelinas DF, et al. Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosis. Neurology 2001; 56: 843-848.
9. Cudkowicz ME, Shefner JM, Schoenfeld DA, et al. A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis. Neurology 2003; 61: 456-464.
10. Brooks BR. Functional scales: summary. Amyotrophic Lateral Sclerosis 2002; 3(Suppl. 1): S13-S18.
11. Kasarkis EJ, Dempsey-Hall L, Malley-Thompson M, et al. Rating the severity of ALS by caregivers over the telephone using the ALSFRS-R. Amyotrophic Lateral Sclerosis 2005; 6: 50-54.
12. Mannino M, Cellura E, Grimaldi G, et al. Telephone follow-up for patients with amyotrophic lateral sclerosis. European Journal of Neurology 2005; 12(Suppl. 2): P2466.
13. World Federation of Neurology. Revised Criteria for Diagnosis of Amyotrophic Lateral Sclerosis. Available at http://www.wfnals.org/ guidelines/1998elescorial/elescorial1998. htm (accessed 1/10/2006) .
14. Cohen J. Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit. Psychological Bulletin 1968; 70: 213-220.
15. Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Family Medicine 2005; 37: 360-363.
16. Drory VE. Non-linear behaviour of the ALSFRS in ALS patients towards the end of life. Amyotrophic Lateral Sclerosis 2005; 6(Suppl. 1): P132.